Erythropoietin Stimulating Agents & Intravenous Iron
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-02ccf432014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
5
2 SME
Lots
2
2 awarded
Published
05 Nov 2021
Other contracts from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)· 10
Most recent notices published by the same contracting authority.
| Title | Type | Value | Published |
|---|---|---|---|
| Information Technology Service Management | contract | — | 08 May 2026 |
| Patient Carer Online Feedback Service | contract | — | 08 May 2026 |
| NP49425 Generic and Biosimilar Transition Medicines | contract | — | 30 Mar 2026 |
| NP884925 Adobe Licence | contract | — | 27 Mar 2026 |
| Automated AST & Bacteria Testing | contract | — | 27 Mar 2026 |
| Sampling & Measuring Products | contract | — | 25 Mar 2026 |
| NP90726l Tildrakizumab (Ilumetri®) | contract | — | 17 Mar 2026 |
| Ophthalmology Equipment | contract | £8.0m | 11 Mar 2026 |
| Insulin Infusion Pumps, Continuous Glucose Monitoring Systems and Associated Consumables | contract | £100.0m | 11 Mar 2026 |
| Single Use Podiatry Instruments | contract | £2.0m | 11 Mar 2026 |
Other contracts awarded to Vifor Pharma UK Limited· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NP49425 Generic and Biosimilar Transition Medicines | contract | — | 19 Dec 2025 |
| Proprietary Drugs | contract | — | 28 Jul 2025 |
| Gastrointestinal, Endocrine, Nutrition & Blood Medicines | contract | — | 25 Jul 2025 |
| NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National | contract | £9.4m | 24 Jul 2025 |
| NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 | contract | — | 24 Jul 2025 |
| NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 | contract | — | 26 Feb 2024 |
| NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 | contract | £17.6m | 26 Feb 2024 |
| Generic, Branded Generic & Proprietary Medicinal Products - Group 13 | contract | — | 14 Feb 2024 |
| Erythropoietin Stimulating Agents & IV Iron | contract | — | 01 Sept 2023 |
| NHS South of England Branded Medicines - Tranche A - September 2023 | contract | £7.6m | 14 Aug 2023 |